Tracy Swan

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Raymond T. Chung, Marc G. Ghany, Kristen Marks et al. · Clinical Infectious Diseases · 2018 · 726 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

Brian R. Edlin, Benjamin Eckhardt, Marla A. Shu et al. · Hepatology · 2015 · 437 citations · Full text

Public Health, Infectious Diseases, Population Health Sciences +12

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

Soumitri Barua, Robert A. Greenwald, Jason Grebely et al. · Annals of Internal Medicine · 2015 · 397 citations · Full text

Pharmacy, Health Policy, Pharmaceutical Policy +17

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial

Jason Grebely, Olav Dalgård, Brian Conway et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 292 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Recommendations for the management of hepatitis C virus infection among people who inject drugs

Jason Grebely, Geert Robaeys, Philip Bruggmann et al. · International Journal of Drug Policy · 2015 · 199 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmacotherapy +12